Related Experiment Video
Updated: Nov 5, 2025
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
[Viral pneumonia in immunocompetent adults]
Clara Lundetoft Clausen1, Thomas Benfield
1clara.lundetoft.clausen@regionh.dk.
Abstract:
In this review, we discuss viral pneumonias in an overall setting. Viruses are involved in about a quarter of all pneumonias, but despite literature in the past couple of decades emphasising this, the clinical effect remains elusive, and almost all hospitalised patients with pneumonia are treated with antibiotics. Thus, improved diagnostic methods and further research on the subject have the potential to benefit the overall treatment of patients with pneumonia, decrease antibiotic overconsumption and accelerate development of new antiviral therapeutics.
Insights
Viral pneumonias are common but often overlooked, leading to overuse of antibiotics. Better diagnostics and research are needed to improve patient care and develop new antiviral treatments.
Area of Science:
- Medicine
- Infectious Diseases
- Pulmonology
Background:
- Viruses cause approximately 25% of all pneumonia cases.
- Despite decades of research, the clinical impact of viral pneumonia remains unclear.
- Most hospitalized pneumonia patients receive antibiotics, indicating a gap in diagnosis and treatment.
Purpose of the Study:
- To review the current understanding of viral pneumonias.
- To highlight the need for improved diagnostic methods for viral pneumonia.
- To emphasize the potential benefits of further research on viral pneumonia.
Main Methods:
- This is a review article.
- Literature search on viral pneumonias over the past two decades.
- Analysis of the clinical significance and treatment of viral pneumonia.
Main Results:
- Viral infections are a significant contributor to pneumonia.
- Current diagnostic and treatment strategies often fail to identify or address viral causes.
- Antibiotic overuse is prevalent in managing pneumonia, partly due to diagnostic challenges.
Conclusions:
- Improved diagnostic tools for viral pneumonia are crucial.
- Further research is essential to elucidate the clinical impact of viral pathogens.
- Advancements could reduce antibiotic consumption and spur antiviral drug development.
More Related Videos
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:29Pneumonia II: Pathophysiology
01:30Pneumonia III: Complications and Assessment
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...